Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001974550 | SCV002215690 | uncertain significance | Pitt-Hopkins syndrome | 2021-06-28 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with glycine at codon 163 of the TCF4 protein (p.Ser163Gly). The serine residue is moderately conserved and there is a small physicochemical difference between serine and glycine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TCF4-related conditions. This variant is not present in population databases (ExAC no frequency). |